deferoxamine and palmitic acid

deferoxamine has been researched along with palmitic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SE; Han, SJ; Jung, IR; Jung, JG; Kang, Y; Kim, DJ; Kim, HJ; Lee, KW; Lee, SA1
Choi, SE; Cui, R; Jeon, JY; Kang, Y; Kim, HJ; Kim, TH; Lee, HJ; Lee, KW; Lee, SJ1

Other Studies

2 other study(ies) available for deferoxamine and palmitic acid

ArticleYear
Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells.
    Molecular and cellular endocrinology, 2015, May-15, Volume: 407

    Topics: Animals; Apoferritins; Benzoates; Cell Death; Cell Line, Tumor; Chlorides; Deferasirox; Deferoxamine; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Iron Chelating Agents; Iron Deficiencies; JNK Mitogen-Activated Protein Kinases; Palmitic Acid; Rats; Receptors, Transferrin; Signal Transduction; Transcription Factor CHOP; Transferrin; Triazoles

2015
Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:2

    Topics: Adult; Animals; Antigens, CD; Case-Control Studies; Cells, Cultured; Deferoxamine; Diabetes Mellitus, Type 2; Enzyme Activation; Gene Knockdown Techniques; Humans; Insulin Resistance; Iron Chelating Agents; Iron Overload; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Skeletal; Palmitic Acid; Receptors, Transferrin

2019